The latest closing stock price for Cartesian Therapeutics as of April 11, 2025 is 10.67.
An investor who bought $1,000 worth of Cartesian Therapeutics stock at the IPO in 2016 would have $-975 today, roughly -1 times their original investment - a -33.51% compound annual growth rate over 9 years.
The all-time high Cartesian Therapeutics stock closing price was 789.90 on November 25, 2016.
The Cartesian Therapeutics 52-week high stock price is 41.87, which is 292.4% above the current share price.
The Cartesian Therapeutics 52-week low stock price is 8.85, which is 17.1% below the current share price.
The average Cartesian Therapeutics stock price for the last 52 weeks is 19.26.
An investor who bought $1,000 worth of Cartesian Therapeutics stock at the IPO in 2016 would have $-975 today, roughly -1 times their original investment - a -33.51% compound annual growth rate over 9 years.
The all-time high Cartesian Therapeutics stock closing price was 789.90 on November 25, 2016.
The Cartesian Therapeutics 52-week high stock price is 41.87, which is 292.4% above the current share price.
The Cartesian Therapeutics 52-week low stock price is 8.85, which is 17.1% below the current share price.
The average Cartesian Therapeutics stock price for the last 52 weeks is 19.26.